InMed Pharmaceuticals (INM) vs PRF Technologies (PRFX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
InMed Pharmaceuticals is the larger company by market cap ($7.5 million vs $3.1 million), about 2.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | INM | PRFX |
|---|---|---|
| Share price | $1.36 | $0.8735 |
| Market cap | $7.47M | $3.06M |
| 1-day change | +2.26% | +1.72% |
| EPS (TTM) | $-2.84 | $-4.09 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.40 | $7.95 |
| 52-week low | $0.575 | $0.851 |
| Distance from 52-week high | -43.33% | -89.01% |
| Average volume | 914.23K | 294.15K |
| Shares outstanding | 5.49M | 3.50M |
| Employees | 6 | 6 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- InMed Pharmaceuticals is about 2.4 times larger than PRF Technologies by market value ($7.47M vs $3.06M).
About InMed Pharmaceuticals
INM stock →InMed Pharmaceuticals Inc. operates as a pharmaceutical drug development company in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 6 employees
About PRF Technologies
PRFX stock →PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia.
Health Care · Biotechnology: Pharmaceutical Preparations · 6 employees
INM vs PRFX FAQ
Which is bigger, InMed Pharmaceuticals or PRF Technologies?
InMed Pharmaceuticals (INM) is larger, with a market capitalization of $7.47M compared with $3.06M for PRF Technologies (PRFX).
Are InMed Pharmaceuticals and PRF Technologies in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.